Epstein barr virus hemophagocytic lymphohistiocytosis related to rituximab use and immunopathogenetic insights-Reference-Cited by-同舟云学术

Epstein barr virus hemophagocytic lymphohistiocytosis related to rituximab use and immunopathogenetic insights

Published:2016-12 Issue:12 Volume:212 Page:1194-1198
ISSN:0344-0338
Container-title:Pathology - Research and Practice
language:en
Short-container-title:Pathology - Research and Practice

Author:

Papageorgiou Sotirios G.,Tsiodras Sotirios,Siakallis Georgios,Bazani Efthimia,Spathis Aris,Poulakou Garyfalia,Korkolopoulou Penelope,Panayiotides Ioannis,Pappa Vasiliki

Publisher

Elsevier BV

Subject

Cell Biology,Pathology and Forensic Medicine

Reference20 articles.

1. Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens;Chellapandian;Br. J. Haematol.,2013

2. Use of rituximab in conjunction with immunosuppressive chemotherapy as a novel therapy for Epstein Barr virus- associated hemophagocytic lymphohistiocytosis;Balamuth;J. Pediatr. Hematol. Oncol.,2007

3. Current preventive strategies and management of Epstein-Barr virus- related post- transplant lymphoproliferative disease in solid organ transplantation in Europe. Results of the ESGICH Questionnaire-based Cross-sectional Survey;San Juan;Clin. Microbiol. Infect.,2015

4. Impact of Epstein Barr virus-related complications after high-risk allo-SCT in the era of pre-emptive rituximab;Garcia-Cadenas;Bone Marrow Transplant.,2015

5. Autoimmune haemolytic anaemia associated with Epstein Barr virus infection as a severe late complication after kidney transplantation and successful treatment with rituximab: case report;Hamilton;BMC Nephrol.,2015

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rituximab as a Therapeutic Strategy in Hemophagocytic Lymphohistiocytosis: Efficacy, Outcomes, and Survival—Insights From a Systematic Review;American Journal of Clinical Oncology;2024-06-27

2. EB Virus-Associated Hemophilic Syndrome: A Case Report and Literature Review;Advances in Clinical Medicine;2024

3. Rituximab-containing immuno-chemotherapy regimens are effective for the elimination of EBV for EBV-HLH with only and mainly B lymphocytes of EBV infection;International Immunopharmacology;2021-07

4. Hemophagocytic lymphohistiocytosis associated with ocrelizumab treatment in a patient with multiple sclerosis;Multiple Sclerosis Journal;2021-03-05

5. Ibrutinib‐associated hemophagocytic lymphohistiocytosis: A case series from Johns Hopkins;American Journal of Hematology;2019-08-22